SLC5A2 and chronic kidney disease: CKD progression in diabetes results from direct glycotoxicity on renal cells as well as from hyperglycemia-induced and SGLT2-mediated glomerular hyperfiltration and tubular hyperreabsorbtion (1, 40, 41).